Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Calcipotriol plus Betamethasone Gel for Scalp Psoriasis
NCT00216879Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Feb 2005
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of AKP01 and betamethasone dipropionate spray 0.05% in psoriasis (2 arms), sponsored by LEO Pharma. Primary endpoints: Incidence of adverse drug reactions and Incidence of adverse events of concern associated with long-term corticosteroid use. Started Feb 2005; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00216879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216879.